Загрузка...
Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine
Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...
Сохранить в:
| Опубликовано в: : | Gynecol Oncol Rep |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7042411/ https://ncbi.nlm.nih.gov/pubmed/32128357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100547 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|